UCSF Team Identifies Proteolytic Peptide Signatures Linked to Chemotherapy Response | GenomeWeb

NEW YORK (GenomeWeb News) – Researchers at the University of California, San Francisco have identified a number of proteolytic peptides that could prove useful as markers of patient response to chemotherapy.

Detailed in a study published this week in Proceedings of the National Academy of Sciences, the work used a variety of mass spectrometry workflows to develop peptide signatures indicative of cell death by chemotherapy.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.